Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice

Nicola Ivan Lorè, Fuad A. Iraqi, Alessandra Bragonzi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans. Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However, clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used an innovative experimental model to dissect whether host genetic background, such as those found in the outbred population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia. Results: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P. aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic profile rather than environmental factors among the CC lines during P. aeruginosa infection. Conclusion: This innovative model system can potentially reproduce the variables responses of disease severity observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic factors, as multiple genetic loci or polymorphic variations.

Original languageEnglish
Article number106
JournalBMC genetics [electronic resource]
Volume16
Issue number1
DOIs
Publication statusPublished - Aug 28 2015

Fingerprint

Pseudomonas aeruginosa
Pneumonia
Pseudomonas Infections
Morbidity
Mortality
Opportunistic Infections
Body Weight
Inborn Genetic Diseases
Body Weight Changes
Genetic Loci
Immunosuppressive Agents
Infection
Cystic Fibrosis
Population
Immune System
Acquired Immunodeficiency Syndrome
Theoretical Models
Survival Rate
Phenotype
Neoplasms

Keywords

  • Acute infection
  • Airway infection
  • Animal model
  • CC mice
  • Disease phenotype
  • Forward genetics
  • P. aeruginosa

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice. / Lorè, Nicola Ivan; Iraqi, Fuad A.; Bragonzi, Alessandra.

In: BMC genetics [electronic resource], Vol. 16, No. 1, 106, 28.08.2015.

Research output: Contribution to journalArticle

@article{e999eedf36ea4c059e1d205702a58e14,
title = "Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice",
abstract = "Background: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans. Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However, clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used an innovative experimental model to dissect whether host genetic background, such as those found in the outbred population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia. Results: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P. aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic profile rather than environmental factors among the CC lines during P. aeruginosa infection. Conclusion: This innovative model system can potentially reproduce the variables responses of disease severity observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic factors, as multiple genetic loci or polymorphic variations.",
keywords = "Acute infection, Airway infection, Animal model, CC mice, Disease phenotype, Forward genetics, P. aeruginosa",
author = "Lor{\`e}, {Nicola Ivan} and Iraqi, {Fuad A.} and Alessandra Bragonzi",
year = "2015",
month = "8",
day = "28",
doi = "10.1186/s12863-015-0260-6",
language = "English",
volume = "16",
journal = "BMC Genetics",
issn = "1471-2156",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice

AU - Lorè, Nicola Ivan

AU - Iraqi, Fuad A.

AU - Bragonzi, Alessandra

PY - 2015/8/28

Y1 - 2015/8/28

N2 - Background: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans. Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However, clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used an innovative experimental model to dissect whether host genetic background, such as those found in the outbred population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia. Results: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P. aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic profile rather than environmental factors among the CC lines during P. aeruginosa infection. Conclusion: This innovative model system can potentially reproduce the variables responses of disease severity observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic factors, as multiple genetic loci or polymorphic variations.

AB - Background: Pseudomonas aeruginosa is one of the top three causes of opportunistic infections in humans. Patients with a compromised immune system, due to immunosuppressive therapies or underlying diseases such as cancer, AIDS or the hereditary disease cystic fibrosis, are at risk of developing P. aeruginosa infection. However, clinical evidence indicates extremely variable outcomes of P. aeruginosa infections in individuals at risk, suggesting that host multi-complex genetic traits may influence the severity of this opportunistic infection. Here, we have used an innovative experimental model to dissect whether host genetic background, such as those found in the outbred population, could influence the risk of morbidity and mortality to P. aeruginosa pneumonia. Results: A highly genetically-diverse mouse resource population, Collaborative Cross (CC) mice, was infected with a clinical strain of P. aeruginosa and subsequently monitored for mortality, mean survival time, and morbidity, change in body weight for seven days post infection. Disease phenotypes ranged from complete resistance and recovery of body weight to lethal disease. Initial variables, including body weight, age and gender, have limited influence on P. aeruginosa outcome, emphasizing the role of host genetic background in defining the risk of morbidity and mortality. When broad-sense heritability of phenotypic traits was evaluated, it confirmed the influence of genetic profile rather than environmental factors among the CC lines during P. aeruginosa infection. Conclusion: This innovative model system can potentially reproduce the variables responses of disease severity observed in humans during P. aeruginosa pneumonia. Our results demonstrated that a widely-marked differential response to P. aeruginosa airway infection in term of morbidity and mortality, is mainly affected by host genetic factors, as multiple genetic loci or polymorphic variations.

KW - Acute infection

KW - Airway infection

KW - Animal model

KW - CC mice

KW - Disease phenotype

KW - Forward genetics

KW - P. aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=84940204260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940204260&partnerID=8YFLogxK

U2 - 10.1186/s12863-015-0260-6

DO - 10.1186/s12863-015-0260-6

M3 - Article

AN - SCOPUS:84940204260

VL - 16

JO - BMC Genetics

JF - BMC Genetics

SN - 1471-2156

IS - 1

M1 - 106

ER -